Abstract
Fatty acid oxidation has been studied with the tritium release assay in cultured fibroblasts from patients with defects in β-oxidation and in the mitochondrial respiratory chain. Cells from all patients with β-oxidation defects and cells from 10 of 16 patients with respiratory chain defects showed an impairment of fatty acid oxidation. The result of the tritium release assay is not only dependent on the proper function of the β-oxidation cycle but is also influenced by the reoxidation of reduced cofactors. The assay can thus be used to study the expression of respiratory chain defects in cultured fibroblasts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Bennett MJ, Weinberger MJ, Sherwood WG, Burlina AB (1994) Secondary 3-hydroxydicarboxylic aciduria mimicking long-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency. J Inher Metab Dis 17: 283-286.
Coates PM (1994) New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders. Eur J Pediatr 153: 49-56.
De Vivo DC (1993) The expanding clinical spectrum of mitochondrial diseases. Brain Dev 15: 1-22.
DiMauro S, Moraes CT (1993) Mitochondrial encephalomyopathies. Arch Neurol 50: 1197-1208.
Hagenfeldt L, von Dübeln U, Holme E, et al (1990) 3-Hydroxydicarboxylic aciduria — a fatty acid oxidation defect with severe prognosis. J Pediatr 116: 387-392.
Hagenfeldt L, Venizelos N, von Dübeln U (1995) Clinical and biochemical presentation of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency J Inher Metab Dis 18: 245-248.
Hartree E F (1972) Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem 48: 422-427.
Larsson NG, Tulinius MH, Holme E, et al (1992) Segregation and manifestations of the mtDNA tRNA (Lys) A → G (8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am J Hum Genet 51: 1201-1212.
Manning NJ, Olpin SE, Pollitt RJ, Webley J (1990) Comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for detection of fatty acid oxidation defects in intact cultured fibroblasts. J Inher Metab Dis 13: 58-68.
Mayatepek KE, Wanders RJA, Hoffmann GE (1995) Mitochondropathy presenting with non-ketotic hypoglycaemia as 3-hydroxydicarboxylic aciduria. J Inher Metab Dis 18: 249-252.
Moon A, Rhead WJ (1987) Complementation analysis of fatty acid oxidation disorders. J Clin Invest 79: 59-64.
Olpin SE, Manning NJ, Pollitt RJ, Clarke S (1997) Improved detection of long-chain fatty acid oxidation defects in intact cells using [9,10-3H]oleic acid. J Inher Metab Dis 20: 415-419.
Rhead WJ, Wolff JA, Lipson M, et al (1987) Clinical and biochemical variation and family studies in the multiple acyl-CoA dehydrogenation disorders. Pediatr Res 21: 371-376.
Santorelli FM, Mak SC, Vazquezmemije ME, et al (1996) Clinical heterogeneity associated with the mitochondrial DNA T8993C point mutation. Pediatr Res 39: 914-917.
Stanley CA, Hale DE (1994) Genetic disorders of mitochondrial fatty acid oxidation Curr Opin Pediatr 6: 476-481.
Venizelos N, IJlst L, Wanders R, Hagenfeldt L (1994) β-Oxidation enzymes in fibroblasts from patients with 3-hydroxydicarboxylic aciduria. Pediatr Res 36: 111-114.
Watmough NJ, Bindoff LA, Birch-Machin MA, et al (1990) Impaired mitochondrial oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria. J Clin Invest 85: 177-184.
Rights and permissions
About this article
Cite this article
Venizelos, N., von Döbeln, U. & Hagenfeldt, L. Fatty acid oxidation in fibroblasts from patients with defects in β-oxidation and in the respiratory chain. J Inherit Metab Dis 21, 409–415 (1998). https://doi.org/10.1023/A:1005310809714
Issue Date:
DOI: https://doi.org/10.1023/A:1005310809714